Fondazione IRCCS Istituto Neurologico Carlo Besta
Milan, Italy
Location status: Recruiting
NCT Number: NCT07286929
The goal of modern neurooncological surgery is to obtain maximum tumor resection while preserving neurological function. Parietal lobe gliomas often cause attention deficits (hemineglect) that are difficult to differentiate from other deficits. This study aims to evaluate the extent and variation over time of visuo-spatial deficits in patients undergoing surgical removal of parietal lobe gliomas. This will help characterize the cognitive profile of these patients to identify personalized treatment and rehabilitation paths.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Milan, Italy
Location status: Recruiting
This is a single-centre, prospective, cross-sectional, observational study involving 40 patients with high- and low-grade parietal lobe glioma. The study investigates the prevalence of subjects who show a performance in cognitive visuo-spatial tests below the cut-off of the normative sample. It evaluates associations with patient-reported outcome measures (ADL, IADL), clinical-demographic aspects, radiological data (MRI), and histological/molecular data. Assessments occur at screening (pre-surgery), and at follow-up visits (3-4 months and 6 months post-surgery). Neuropsychological tests include Line Bisection, Bell and Letter Cancellation, Reading test, Apple Cancellation, and Fluff test.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline (pre-surgery), 3-4 months post-surgery, 6 months post-surgery.
Prevalence of patients with a score below the cut-off in specific neuropsychological tests for visuo-spatial aspects (Line Bisection, Bell/Letter Cancellation, Apple Cancellation, Fluff Test) and the extent of change compared to baseline.
Time frame: Up to 6 months post-surgery
Correlation between visuo-spatial deficit scores and MRI data (FLAIR volume, T1 contrast, necrosis, localization).
Time frame: Up to 6 months post-surgery.
Correlation between visuo-spatial scores and hemispheric dominance, age, sex, and education.
Time frame: Time Frame: Up to 6 months post-surgery.
Correlation between visuo-spatial scores and Karnofsky Performance Status (KPS).
Time frame: Up to 6 months post-surgery.
Correlation between visuo-spatial scores and tumor grade, histological and molecular features.
Contact information is provided by the study sponsor or research team.
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Other
Acronym: neGLIO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07076498
Brain Diseases, Brain Neoplasms
Houston, Texas, United States
View Trial DetailsNCT07464925
Astrocytoma, Glioblastoma
Tampa, Florida, United States
View Trial DetailsNCT07416188
Astrocytoma, Brain Cancer
Bethesda, Maryland, United States
View Trial DetailsNCT06161519
Astrocytoma, Brain Diseases
Bethesda, Maryland, United States
View Trial Details